Literature DB >> 16495496

Characterization of small focal liver lesions using real-time contrast-enhanced sonography: diagnostic performance analysis in 200 patients.

Hui-Xiong Xu1, Guang-Jian Liu, Ming-De Lu, Xiao-Yan Xie, Zuo-Feng Xu, Yan-Ling Zheng, Jin-Yu Liang.   

Abstract

OBJECTIVE: The purpose of this study was to assess the diagnostic performance of real-time contrast-enhanced sonography in characterization of small focal liver lesions (FLLs; < or = 3.0 cm in diameter).
METHODS: Two hundred small FLLs in 200 patients were examined by contrast-enhanced sonography using a contrast-specific mode of contrast pulse sequencing and a sulfur hexafluoride-filled microbubble contrast agent. The sonographic images were reviewed by 2 independent readers. A 5-point confidence level was used to discriminate malignant from benign FLLs, and specific diagnoses were recorded. The diagnostic performances were evaluated by receiver operating characteristic (ROC) analysis, and the interobserver agreement was analyzed by weighted kappa statistics.
RESULTS: After review of contrast-enhanced sonography, ROC analysis revealed significant improvement in differentiating between malignant and benign small FLLs that the areas under the ROC curve were 0.856 at baseline sonography versus 0.954 at contrast-enhanced sonography for reader 1 (P < .001) and 0.857 versus 0.954 for reader 2 (P = .003). The sensitivity, negative predictive value, and accuracy for both readers also improved significantly after contrast agent administration (all P < .001). A better result of specific diagnosis was obtained (38.5% [77/200] at baseline sonography versus 80.5% [161/200] at contrast-enhanced sonography for reader 1 and 34.5% [69/200] versus 80.5% [161/200] for reader 2; both P < .001) after contrast agent administration, and a better interobserver agreement was achieved (kappa = 0.425 at baseline sonography versus 0.716 at contrast-enhanced sonography).
CONCLUSIONS: Real-time contrast-enhanced sonography improves the diagnostic performance in small FLLs compared with baseline sonography.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16495496     DOI: 10.7863/jum.2006.25.3.349

Source DB:  PubMed          Journal:  J Ultrasound Med        ISSN: 0278-4297            Impact factor:   2.153


  25 in total

1.  Contrast-enhanced ultrasound: The evolving applications.

Authors:  Hui-Xiong Xu
Journal:  World J Radiol       Date:  2009-12-31

2.  Detection of focal liver lesions in cirrhotic liver using contrast-enhanced ultrasound.

Authors:  Grace Lai-Hung Wong; Hui-Xiong Xu; Xiao-Yan Xie
Journal:  World J Radiol       Date:  2009-12-31

3.  Assessment of arterial hypervascularity of hepatocellular carcinoma: comparison of contrast-enhanced US and gadoxetate disodium-enhanced MR imaging.

Authors:  Katsutoshi Sugimoto; Fuminori Moriyasu; Junji Shiraishi; Kazuhiro Saito; Junichi Taira; Toru Saguchi; Yasuharu Imai
Journal:  Eur Radiol       Date:  2012-01-24       Impact factor: 5.315

4.  Microbubble-enhanced ultrasound exposure improves gene transfer in vascular endothelial cells.

Authors:  Fang Nie; Hui-Xiong Xu; Qing Tang; Ming-De Lu
Journal:  World J Gastroenterol       Date:  2006-12-14       Impact factor: 5.742

5.  Diagnostic performance of contrast-enhanced ultrasound for complex cystic focal liver lesions: blinded reader study.

Authors:  Man-Xia Lin; Hui-Xiong Xu; Ming-De Lu; Xiao-Yan Xie; Li-Da Chen; Zuo-Feng Xu; Guang-Jian Liu; Xiao-Hua Xie; Jin-Yu Liang; Zhu Wang
Journal:  Eur Radiol       Date:  2008-09-16       Impact factor: 5.315

Review 6.  The current status of contrast-enhanced ultrasound in China.

Authors:  Hui-Xiong Xu; Ming-De Lu
Journal:  J Med Ultrason (2001)       Date:  2010-04-21       Impact factor: 1.314

7.  Era of diagnostic and interventional ultrasound.

Authors:  Hui-Xiong Xu
Journal:  World J Radiol       Date:  2011-05-28

Review 8.  Rare cystic liver lesions: a diagnostic and managing challenge.

Authors:  Andreas Bakoyiannis; Spiros Delis; Charina Triantopoulou; Christos Dervenis
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

9.  Hepatocellular carcinoma after ablation: the imaging follow-up scheme.

Authors:  Lin-Na Liu; Hui-Xiong Xu; Yi-Feng Zhang; Jun-Mei Xu
Journal:  World J Gastroenterol       Date:  2013-02-14       Impact factor: 5.742

Review 10.  Management of hepatocellular carcinoma: The role of contrast-enhanced ultrasound.

Authors:  Shu-Guang Zheng; Hui-Xiong Xu; Lin-Na Liu
Journal:  World J Radiol       Date:  2014-01-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.